UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets

British journal of cancer, 2014-03, Vol.110 (6), p.1472-1480

2014

Volltextzugriff (PDF)

A triad of costimulatory molecules synergize to amplify T-cell activation

Cancer research (Chicago, Ill.), 1999-11, Vol.59 (22), p.5800-5807

1999

Volltextzugriff (PDF)

Enhanced Activation of T Cells by Dendritic Cells Engineered to Hyperexpress a Triad of Costimulatory Molecules

JNCI : Journal of the National Cancer Institute, 2000-08, Vol.92 (15), p.1228-1239

2000

Volltextzugriff (PDF)

Acquisition of CD80 (B7-1) by T Cells

The Journal of immunology (1950), 2001-02, Vol.166 (4), p.2505-2513

2001

Volltextzugriff (PDF)

The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies

Cell death & disease, 2013-06, Vol.4 (6), p.e682-e682

2013

Volltextzugriff (PDF)

Irradiation of Tumor Cells Up-Regulates Fas and Enhances CTL Lytic Activity and CTL Adoptive Immunotherapy

The Journal of immunology (1950), 2003-06, Vol.170 (12), p.6338-6347

2003

Volltextzugriff (PDF)

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

Vaccine, 1997-04, Vol.15 (6), p.759-768

1997

Volltextzugriff (PDF)

Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity

Cancer research (Chicago, Ill.), 2002-10, Vol.62 (20), p.5770-5777

2002

Volltextzugriff (PDF)

The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation

Vaccine, 1999-02, Vol.17 (7), p.893-903

1999

Volltextzugriff (PDF)

Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines

Cancer research (Chicago, Ill.), 1999-10, Vol.59 (20), p.5106-5111

1999

Volltextzugriff (PDF)

Selective Induction of High Avidity CTL by Altering the Balance of Signals from APC

The Journal of immunology (1950), 2003-03, Vol.170 (5), p.2523-2530

2003

Volltextzugriff (PDF)

Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity

Cancer research (Chicago, Ill.), 1995-08, Vol.55 (16), p.3598-3603

1995

Volltextzugriff (PDF)

Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (11), p.4497-4505

2001

Volltextzugriff (PDF)

Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L)

Human gene therapy, 1999-05, Vol.10 (7), p.1095-1103

1999

Volltextzugriff (PDF)

Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death

International journal of cancer, 2013-08, Vol.133 (3), p.624-636

2013

Volltextzugriff (PDF)

Costimulatory molecules as adjuvants for immunotherapy

Frontiers in bioscience, 2006-01, Vol.11 (1), p.788

2006

Volltextzugriff (PDF)

Modified vaccinia virus Ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (22), p.7942-7949

2003

Volltextzugriff (PDF)

Strategies in the development of recombinant vaccines for colon cancer

Seminars in oncology, 1999-12, Vol.26 (6), p.672-682

1999

Volltextzugriff (PDF)

Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation

Cancer biotherapy & radiopharmaceuticals, 2012-02, Vol.27 (1), p.12-22

2012

Volltextzugriff (PDF)

Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules

Cancer research (Chicago, Ill.), 1994-11, Vol.54 (21), p.5552-5555

1994

Volltextzugriff (PDF)

Vaccination with a recombinant vaccinia vaccine containing the B7‐1 co‐stimulatory molecule causes no significant toxicity and enhances T cell–mediated cytotoxicity

International journal of cancer, 2000-02, Vol.85 (4), p.508-517

2000

Volltextzugriff (PDF)

Combinatorial vaccine strategies and the use of molecular arrays to characterize T-cell activation

Developments in biologicals, 2004, Vol.116, p.27

2004

Volltextzugriff (PDF)

A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate

International journal of cancer, 1995-10, Vol.63 (2), p.231-237

1995

Volltextzugriff (PDF)

Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3)

Vaccine, 2001-12, Vol.20 (5), p.744-755

2001

Volltextzugriff (PDF)

Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules

Vaccine, 2001-05, Vol.19 (25), p.3552-3567

2001

Volltextzugriff (PDF)

1 – 25 von 1.531

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.328)
Mit Volltextzugriff
(1.262)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.525)
Deutsch
(3)
Japanisch
(1)
Spanisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(988)
Life Sciences & Biomedicine
(713)
Humans
(527)
Female
(334)
Male
(332)
Biological And Medical Sciences
(326)
Medical Sciences
(276)
Physical Sciences
(213)
Animals
(207)
Middle Aged
(195)
Adult
(167)
Aged
(149)
Astronomy & Astrophysics
(107)
Mice
(101)
Exact Sciences And Technology
(78)
Fundamental And Applied Biological Sciences. Psychology
(77)
Immunology
(75)
Oncology
(74)
Adolescent
(73)
Physics
(71)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets

A triad of costimulatory molecules synergize to amplify T-cell activation

Enhanced Activation of T Cells by Dendritic Cells Engineered to Hyperexpress a Triad of Costimulatory Molecules

Acquisition of CD80 (B7-1) by T Cells

The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies

Irradiation of Tumor Cells Up-Regulates Fas and Enhances CTL Lytic Activity and CTL Adoptive Immunotherapy

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity

The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation

Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines

Selective Induction of High Avidity CTL by Altering the Balance of Signals from APC

Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity

Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects

Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L)

Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death

Costimulatory molecules as adjuvants for immunotherapy

Modified vaccinia virus Ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses

Strategies in the development of recombinant vaccines for colon cancer

Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation

Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules

Vaccination with a recombinant vaccinia vaccine containing the B7‐1 co‐stimulatory molecule causes no significant toxicity and enhances T cell–mediated cytotoxicity

Combinatorial vaccine strategies and the use of molecular arrays to characterize T-cell activation

A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate

Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3)

Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules

Suchergebnisse filtern